Correlation between carbapenem consumption and antimicrobial resistance rates of acinetobacter baumannii in a university-affiliated hospital in China

Journal of Clinical Pharmacology

Volumn 53, Issue 1, 2013, Pages 96-102

  Cao, Jia ^a   Song, Wei ^a   Gu, Bing ^a   Mei, Ya Ning ^a   Tang, Jian Ping ^a   Meng, Ling ^a   Yang, Chang Qing ^b   Wang, Huijuan ^c   Zhou, Hong ^c  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Acinetobacter baumannii; Antimicrobial resistance; Carbapenem consumption; Cross resistance

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PANIPENEM PLUS BETAMIPRON; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHINA; CORRELATION ANALYSIS; CROSS RESISTANCE; DRUG DOSE REGIMEN; DRUG USE; NONHUMAN; UNIVERSITY HOSPITAL;

ACINETOBACTER BAUMANNII; ANTI-INFECTIVE AGENTS; CARBAPENEMS; CHINA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG UTILIZATION; HOSPITALS, UNIVERSITY; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 84877857827     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270011435988     Document Type: Article

References (34)

1. Higgins PG, Dammhayn C, Hackel M, Seifert H. Global spread of carbapenem-resistant Acinetobacter baumannii . J Antimicrob Chemoth . 2010;65:233-238.
2. Zarrilli R, Giannouli M, Tomasone F, Triassi M, Tsakris A. Carbapenem resistance in Acinetobacter baumannii the molecular epidemic features of an emerging problem in health care facilities. J Infect Dev Ctries . 2009;3:335-341.
3. Mak JK, Kim MJ, Pham J, Tapsall J, White PA. Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii . J Antimicrob Chem . 2009;63:47-54.
4. Park YS, Lee H, Lee KS, et al. Extensively drug-resistant Acinetobacter baumannii : risk factors for acquisition and prevalent OXA-type carbapenemases-A multicentre study. Int J Antimicrob . 2010;36:430-435.
5. Valencia R, Arroyo LA, Conde M, et al. Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital. Infect Cont Hosp Epidemiol . 2009;30:257-263.
6. Katsaragakis S, Markogiannakis H, Samara E, et al. Predictors of mortality of Acinetobacter baumannii infections: a 2-year prospective study in a Greek surgical intensive care unit. Am J Infect Control . 2010;38:631-635.
7. Cisneros JM, Rodr?uez-Ba? J, Ferndez-Cuenca F, et al. Riskfactors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study. Antimicrob Agents Chemother . 2005;11:874-879.
8. Pakyz AL, Oinonen M, Polk RE. Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa . Antimicrob Agents Chemother . 2009;53:1983-1986.
9. Maortua H, Canut A, Ibanez B, et al. Relaci? entre la resistencia bacteriana intrahospitalaria y el consumo de antimicrobianos durante un per?do de 13 a?s. Enferm Infec Micr Cl . 2009;27:441-448.
10. Ye JJ, Huang CT, Shie SS, et al. Multidrug resistant Acinetobacter baumannii: risk factors for appearance of imipenem resistant strains on patients formerly with susceptible strains. PLoS ONE . 2010;5:e9947.
11. Gordon NC, Wareham DW. Multidrug-resistant Acinetobacter baumannii : mechanisms of virulence and resistance. Int J Antimicrob Agents . 2010;35:219-226.
12. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: 16th Informational Supplement . M100-S16. Wayne, PA: Clinical and Laboratory Standards Institute; 2006.
13. Mendes RE, Bell JM, Turnidge JD, et al. Emergence and widespread dissemination of OXA-23,-24/40 and-58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. J Antimicrob Chemother . 2009;63:55-59.
14. Zhou M, Huang M, Mei YN. Analysis of OXA-23 carbapenemaseencoding drug resistance correlated gene of Acinetobacter baumannii . Acta Universitatis Medicinalis Naning (Natural Science) . 2009;28:1142-1145.
15. Zhao WS, Jiang SF, Gu B, et al. Investigation on resistance to carbopenems and resistance genotypes of Acinetobacter baumannii . Acta Universitatis Medicinalis Naning (Natural Science) . 2006 ;26:929-932.
16. Hitier C, Poirel L, Lambert T, Nordmann P. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii . Antimicrob Agents Chemother . 2005;49:3198-3202.
17. Adams-Haduch JM, Paterson DL, Sidjabat HE, et al. Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania. Antimicrobial Agents Chemother . 2008;11:3837-3844.
18. Gu B, Tong MQ, Zhao WJ, et al. Prevalence and characterization of class I integrons among Pseudomonas aeruginosa and Acinetobacter baumannii isolates from patients in Nanjing, China. J Clin Microbiol . 2007;45:241-242.
19. Wang YL, Huang M, Mei YN, et al. Study on mechanism of quinolones resistance in Acinetobacter baumannii . Chin J Infect Chemother . 2008;8:266-270.
20. Zhao WS, Jiang SF, Gu B, et al. Survey on gene mutations of quinolone-resistant Acinetobacter baumannii in Nanjing region of China. Chin J Clin Lab Sci . 2007;25:90-92.
21. Zhao WS, Huang PJ, Liu GY, et al. Investigation for main types of aminoglycoside-modifying gene of Acinetobacter baumannii in Nanjing region. Chin J Clin Lab Sci . 2005;23:334-336.
22. Zhou YM, Zhao WS, Jiang SF, et al. Detection resistance of 70 strains Acinetobacter baumannii and genotypes of beta-lactamases. Jiangsu Med J . 2006;32:923-924.
23. Jiang SF, Qiu H, Zhou YM, et al. Detection on resistance and main genotypes of beta-lactamases 75 strains of Acinetobacter baumannnii in Nanjing District. J Jiangsu Univ . 2007;17:265-267.
24. Arroyo LA, Mateos I, Gonzez V, Aznar J. In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi-and pandrug-resistant clinical isolates of Acinetobacter baumannii group. Antimicrob Agents Chemother . 2009;53:1295-1296.
25. Kiratisin P, Apisarnthanarak A, Kaewdaeng S. Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates. Int J Antimicrob Agents . 2010;36:243-246.
26. Lim TP, Ledesma KR, Chang KT, et al. Quantitative assessment of combination antimicrobial therapy against multidrug-resistant Acinetobacter baumannii . Antimicrob Agents Chemother . 2008;52: 2898-2903.
27. Credito K, Kosowska-Shick K, Appelbaum PC. Mutant prevention concentration (MPC) of four carbapenems against gram-negative rods. Antimicrob Agents Chemother . 2010;54:2692-2695.
28. Cui JC, Liu YN, Chen LA. Mutant prevention concentration of tigecycline for carbapenem-susceptible and resistant Acinetobacter baumannii . J Antibiot . 2010;63:29-31.
29. Kiratisin P, Apisarnthanarak A, Kaewdaeng S. Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates. Int J Antimicrob Agents . 2010;36:243-246.
30. Jaruratanasirikul S, Sriwiriyajan S, Punyo J. Comparison of the pharmacodynamics of meropenem in patients with ventilatorassociated pneumonia following administration by 3-hour infusion or bolus injection. Antimicrob Agents Chemother . 2005;49: 1337-1339.
31. Jaruratanasirikul S, Sudsai T. Comparison of the pharmacodynamics of imipenem in patients with ventilator-associated pneumonia following administration by 2 or 0.5 h infusion. J Antimicrob Chemoth . 2009;63:560-563.
32. Koomanachai P, Bulik CC, Kuti JL, Nicolau DP. Pharmacodynamic modeling of intravenous antibiotics against gram-negative bacteria collected in the United States. Clin Ther . 2010;32:766-779.
33. Nemec A, KrovL, MaixnerovM, et al. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. J Antimicrob Chemother . 2008;62:484-489.
34. Touati A, Brasme L, Benallaoua S, Gharout A, Madoux J, De Champs C. First report of qnrB-producing Enterobacter cloacae and qnrA-producing Acinetobacter baumannii recovered from Algerian hospitals. Diagn Microbiol Infect Dis . 2008;60: 287-290.